electrochemical mediator displacement LAMP is the possibility of simultaneous target amplification and detection in multiplex assays, which presents an especially attractive option for real-time applications. Recent…
such that they retain folded structure and function and behave in miniaturized, highly multiplexed quantitative assays as if they are in free solution. We have utilized protein microarrays consisting
long presented forensic serologists with a significant challenge. Current antibody and enzyme activity based assays used by forensic practitioners for biological stain identification yield only presumptive results…
genotypes using an HPV type-specific E7 PCR bead-based multiplex genotyping assay (TS-MPG) which is a laboratory-developed method for the detection of HPV. Results: The prevalence
transformed infectious disease management, offering rapid and accurate pathogen identification.Technologies like PCR, sequencing, and multiplex assays are vital for diagnosing a wide range of infections, including viral…
week after PRP or SVF injections and tested for concentrations of 41 cytokines (Multiplex Assay). Findings: PRP subgroup performed better compared with the SVF subgroup according to KOOS
disease detection. Novel advancements include the implementation of high-throughput technologies, such as multiplex assays and digital immunoassays, which allow for the simultaneous detection of multiple biomarkers with…
production was calculated, and cell viability was determined using a microplate reader. MILLIPLEX Multiplex Assay analyzed expression of IL-6, IL-10, and TNF-α from RAW264.7 cells when stimulated
techniques for disease detection, covering topics such as digital pathology, Artificial Intelligence (AI) integration, multiplexed assays, and tissue engineering. These trends are reshaping the landscape of…
Technologies, uses a fast PCR fast-cycling PCR technology, which allows in a single multiplex assay, in less than 2 hours, the amplification of 20 autosomal STR loci
Gene Technologies, uses a fast PCR fastcycling PCR technology, which allows in a single multiplex assay, in less than 2 hours, the amplification of 20 autosomal STR loci
spatial organization of the sample. Our objective is to develop and optimize highly multiplexed assays for characterization of signalling heterogeneity in tissue microarrays of human tumours and describe the modelling
coronary and peripheral blood samples, either before or after angioplasty were determined by multiplexing assay. Baseline distribution of coronary cytokines, or its modification after angioplasty, was evaluated according
Blood samples were collected from PD patients and their match controls, and then biomarkers multiplex assay from Milliplex was used to assess the levels
impairment. Prioritized linkage analysis and homozygosity mapping were conducted. A next-generation sequencing-based multiplexing assay that encompasses the 120 known hearing loss genes was also used. For genes involved
extracted from saliva and urine samples to identify cancer-related viruses and SNPs through multiplex assays in a single reaction. At the current stage of development, both assays identify cancer
extracted from saliva and urine samples to identify cancer-related viruses and SNPs through multiplex assays in a single reaction. At the current stage of development, both assays identify cancer
impairment. Prioritized linkage analysis and homozygosity mapping was conducted. A next-generation sequencing-based multiplexing assay that encompasses the 120 known hearing loss genes was also used. For genes involved
compartments have been attempted to be produced for utilizing MPs in cell/drug delivery, multiplexing assays, actuators, as self-assembly building blocks, as well as photonic devices. Several methods have
status and prognosis by combining both clinico-epidemiologic variables and either serological multiplex assays of HPV or multiple imputation of HPV status. Sensitivity, specificity and accuracy between these methods
procedure. Cytokine levels of venous tissue lysate and serum samples were determined using a multiplex assay. Results: Thirteen patients (65%) were classified as clinical CEAP Class 2 or 3, with
using an automated chemistry analyzer. Serum disease risk biomarkers were measured using bead-based multiplex assays as secondary, exploratory measures. Data were statistically analyzed using repeated measures ANOVA
quantification was done by sandwich ELISA and cytokines quantification by Multiplex assay. In smokers and non-smokers groups, diseased sites showed higher levels of LL-37 in comparison with healthy
Prioritized linkage analysis and homozygosity mapping for was conducted. A next-generation sequencing-based multiplexing assay that encompasses the 120 known hearing loss genes was also used. For genes involved
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.